Recent studies demonstrated that EBV activates SREBP-dependent mevalonate and fatty acid synthesis pathways early after infection, and that LMP1 alone is sufficient to drive SREBP1/FASN activity and lipid droplet biogenesis, positioning lipogenesis as a core latency output [18,85]. The gene discussed is FASN; the disease is infection.